Project Grant R44AG082602

Award Date 2/15/24
Completion Date 1/31/25
Dollars Obligated $1.2M
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Astoria, NY 11104, USA
Similar Awards
This $811,228 Project Grant awarded by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) supports the development of the At-Home Health Station (AHS) by B.A. Maze, Inc. The AHS is a plug-and-play modular system designed to simplify digital experiences and enable remote patient monitoring for individuals with cognitive impairment and Alzheimer's disease and related dementias (ADRD). The Phase I effort will focus on usability testing and feedback to refine the...
This $2,202,905 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) aims to develop an integrated, machine learning-enhanced electronic self-administered gerocognitive examination (ESAGE) that can accurately detect and monitor cognitive impairment, including in underserved populations. The key products/services to be delivered include: Enhancing the scoring and predictive ability of ESAGE using behavioral data, metadata, and machine learning methods...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $400,000 to Foresightcares Inc., a minority-owned and woman-owned technology company based in Matthews, North Carolina. The funds will support the development and validation of "AVA", an AI-powered, video-based mobile application for reliable and accessible in-home fall risk assessments of older adults. The project aims to validate AVA's AI algorithms and evaluate its feasibility and...
The National Institute on Aging (NIA) awarded Beaver Health, Inc. a $499,961 Project Grant under the Aging Research Federal Grant Program (CFDA 93.866) to develop OASIS, a personalized and culturally responsive mindfulness virtual coaching platform to support Alzheimer's disease and related dementia (AD/ADRD) caregivers. This 12-month Phase 1 project aims to create a prototype of OASIS and test its initial usability and feasibility for diverse AD/ADRD family caregivers. OASIS leverages...
This $170,593 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports the development and pilot testing of a novel digital platform, called iPathD, to improve screening and access to treatment for depression among care partners of people living with Alzheimer's disease and related dementias. The project, led by Dartmouth-Hitchcock Clinic in collaboration with Dartmouth College, aims to optimize the iPathD platform to facilitate depression...
This Project Grant award from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) provides $2,331,816 to Onward Health, Inc., a California-based small business, to develop and evaluate a door-through-door rideshare service with trained companion drivers to improve transportation access and support for older adults and individuals with Alzheimer's disease and related dementias (AD/ADRD). The key objectives are to: 1) conduct a randomized controlled trial to assess...
This $199,987 Project Grant award from the National Institute on Disability, Independent Living, and Rehabilitation Research (CFDA# 93.433) supports the development and evaluation of "EMPOWER@HOME", an internet-based cognitive behavioral therapy program designed for homebound older adults with depression. The project aims to enhance access to mental health services for this population by integrating the therapy program with lay coaches from community aging service agencies. Key...
The Department of Health and Human Services' National Institutes of Health's National Institute on Aging awarded $865,905 under the Aging Research program (CFDA 93.866) to Careband, Inc. to develop the Appraise to Assist system. This project grant will support Careband and its partner Eperture LLC to engineer a system integrating Careband's wearable device and Eperture's tablet platform. The system aims to passively and unobtrusively monitor, empirically measure, and facilitate engagement...
This $1,177,500 project grant, awarded by the National Institute on Aging under the Aging Research program (CFDA 93.866), supports the development of the Arizona State University Roybal Center for Older Adults Living Alone with Cognitive Decline. The Center will build infrastructure and conduct clinical trials of technology-enabled behavioral and lifestyle interventions to delay Alzheimer's disease and related dementias, and improve quality of life, in older adults living alone with cognitive...
The National Institute on Aging (NIA) awarded Koronis Biomedical Technologies Corporation (KBT) a $1,010,368 Project Grant under the Aging Research federal grant program (CFDA 93.866) to develop and validate an interactive gaming platform to facilitate cognitive interventions for individuals living with mild cognitive impairment (MCI), Alzheimer's disease (AD), and other related dementias. The proposed cognitive intervention system aims to provide an affordable, in-home solution that helps...

INNOVATIVE WEB-BASED SERVICE PLATFORM CALLED ADULT WELLBEING CHECKUP (AWC) TO ASSESS OLDER ADULTS WELLBEING, OBTAIN EVIDENCE-BASED RECOMMENDATIONS, AND RECEIVE SUPPORT TO TAKE ACTION - PROJECT SUMMARY / ABSTRACT OLDER ADULTS IN AMERICA ARE LIVING LONGER, AND THERE ARE MORE OF THEM THAN AT ANY OTHER TIME IN THE COUNTRY'S HISTORY. U.S. ADULTS AGED 65 AND OLDER ARE EXPECTED TO INCREASE FROM 54 MILLION IN 2020 TO OVER 80 MILLION BY 2040. OLDER ADULTS ARE AT RISK FOR POOR HEALTH IN MANY AREAS OF LIFE, INCLUDING PHYSICAL, MENTAL, SOCIAL, AND FINANCIAL HEALTH. THEY WANT TO AGE SUCCESSFULLY AS THEY SEEK INFORMATION FROM THEIR HEALTH CARE PROVIDERS AND PUBLICLY AVAILABLE SOURCES. OVER 40% OF ADULTS USE THE INTERNET FOR HEALTH INFORMATION, ALTHOUGH THERE IS MISTRUST AND CONFUSION BECAUSE THE AVAILABILITY OF INFORMATION IS GENERIC AND SCATTERED THROUGH MANY DIFFERENT RESOURCES. FOR THIS FAST TRACK SBIR PROJECT, WE PROPOSE THE ADULT WELLBEING CHECKUP (AWC) - AN INNOVATIVE AND INFORMATIVE ASSESSMENT AND RECOMMENDATION TOOL THAT WILL HELP OLDER ADULTS ASSESS THEIR WELLBEING IN TWELVE DIFFERENT DOMAINS AND THEN RECEIVE PERSONALIZED GUIDANCE (BASED ON A COLLECTIVELY INTELLIGENT HYBRID REASONING METHODOLOGY) ON HOW TO IMPROVE WELLBEING IN DOMAINS THAT WERE LOW-SCORING AND WANT TO IMPROVE. AWC WILL BE DESIGNED AND DEVELOPED BY BELLAGE, LED BY PRINCIPAL INVESTIGATOR (PI), JAMES FIRMAN, IN COLLABORATION WITH YONG CHOI AND STEPHEN ENGELS, AND SUPPORTED BY BENTEN TECHNOLOGIES. THE SPECIFIC AIMS OF PHASE I ARE: 1) DEVELOP A PROTOTYPE OF THE AWC WITH PERSONALIZED RECOMMENDATIONS IN TWO OF THE TWELVE DOMAINS FROM FORMATIVE RESEARCH; 2) CONDUCT A 4-WEEK PILOT WITH 8 OLDER ADULT CARE PARTNERS (CPS) AND 8 OLDER ADULT NON-CPS FROM THREE SENIOR CENTERS TO ASSESS FEASIBILITY (ENGAGEMENT, USABILITY, AND ACCEPTANCE). THE SPECIFIC AIMS OF PHASE II ARE TO 1) MODIFY THE AWC PROTOTYPE FOR COMMERCIALIZATION AND PROVIDE PERSONALIZED RECOMMENDATIONS FOR MORE WELLBEING DOMAINS, AND 2) CONDUCT A RANDOMIZED CONTROL TRIAL (RCT) WITH 25 OLDER ADULT CPS AND 25 OLDER ADULT NON-CPS IN EIGHT RESEARCH SITES EXAMINING THREE OF THE TWELVE DOMAINS (I.E., LONELINESS, PHYSICAL HEALTH, MENTAL HEALTH) TO SIGNIFICANTLY IMPROVE ENGAGEMENT, SELF-EFFICACY, AND WELLBEING ON ONE OR MORE DOMAINS. THE SHORT-TERM IMPACT WILL BE THE FEASIBILITY, ACCEPTANCE, AND ENGAGEMENT OF OLDER ADULTS WITH THE AWC PLATFORM. THEN, IN PHASE II, IF SUCCESSFUL, THIS STUDY WILL DEMONSTRATE THE DEVELOPMENT AND IMPLEMENTATION OF PERSONALIZED GUIDANCE CAN RESULT IN BEHAVIOR CHANGE AMONG OLDER ADULTS. FURTHERMORE, THE ASSESSMENT COULD IMPROVE WELLBEING MEASUREMENT FOR STATE-FUNDED PROGRAMS AND ORGANIZATIONS, ALLOWING LONGITUDINAL DATA COLLECTION TO PROMPT FUTURE FUNDING AND DEVELOPMENT. FOR FUTURE RESEARCH, WE WOULD FURTHER DEVELOP THE PLATFORM TO PROVIDE PERSONALIZED RECOMMENDATIONS FOR THE REMAINING NINE DOMAINS. ULTIMATELY, THIS SERVICE COULD BE A GUIDANCE SYSTEM AND PREVENTATIVE CARE INTERVENTION FOR MANY ASPECTS OF LIFE FOR OLDER ADULTS.

Posted 2/2/24, 12:00 AM